Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy-Reference-Cited by-同舟云学术

Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy

Published:2015-03-27 Issue:5 Volume:2 Page:518-533
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Dali Christine í¹,Barton Norman W.²,Farah Mohamed H.³,Moldovan Mihai⁴⁵,Månsson Jan‐Eric⁶,Nair Nitin²,Dunø Morten¹,Risom Lotte¹,Cao Hongmei²,Pan Luying²,Sellos‐Moura Marcia²,Corse Andrea M.³,Krarup Christian⁴⁵

Affiliation:

1. Department of Clinical Genetics Rigshospitalet Copenhagen Denmark

2. Shire Lexington Massachusetts

3. Department of Neurology Johns Hopkins Medical Institutions Baltimore Maryland

4. Department of Clinical Neurophysiology Rigshospitalet Copenhagen Denmark

5. Department of Neuroscience and Pharmacology University of Copenhagen Copenhagen Denmark

6. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Gothenburg Sweden

Funder

Danish Medical Research Council

Lundbeck Foundation

Novo Nordisk Foundation

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.193

Reference42 articles.

1. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options

2. Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation

3. Acquired versus familial demyelinative neuropathies in children

4. Neurophysiology and MRI in late-infantile metachromatic leukodystrophy

5. Lysosulfatide (Sulfogalactosylsphingosine) Accumulation in Tissues from Patients with Metachromatic Leukodystrophy

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States;Cytotherapy;2024-07

2. Metachromatic leukodystrophy: A story of hope woven from sorrow;Molecular Therapy;2024-05

3. Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment;Molecular Genetics and Metabolism;2024-05

4. Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management;European Journal of Paediatric Neurology;2024-03

5. In Silico Structural Modeling and Binding Site Analysis of Cerebroside Sulfotransferase (CST): A Therapeutic Target for Developing Substrate Reduction Therapy for Metachromatic Leukodystrophy;ACS Omega;2024-02-23